Trial Profile
Multicentre study of Triple Therapy with Boceprevir or Telaprevir in HCV Treatment-Experience Patients with Advanced Hepatic Fibrosis in clinical practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Telaprevir (Primary)
- Indications Hepatic fibrosis
- Focus Therapeutic Use
- 17 Dec 2015 New trial record